![Anders Gabrielsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Gabrielsen
Director/Miembro de la Junta en KANCERA AB .
Origen de la red de primer grado Anders Gabrielsen.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Karolinska Institutet
95
| College/University | Other Consumer Services | 95 |
14
| Public Company | Pharmaceuticals: Major | 14 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anders Gabrielsen a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Karolinska University Hospital
![]() Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Uppsala | College/University | Doctorate Degree Graduate Degree Masters Business Admin Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
Royal Swedish Academy of Sciences
![]() Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Director/Board Member Graduate Degree Doctorate Degree | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
KLARIA PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Karolinska Institutet Innovations AB
![]() Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Palette Life Sciences AB
![]() Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
Athera Biotechnologies AB
![]() Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
NEOS AB | Medical Specialties | Director/Board Member Founder Founder | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
NovaSAID AB
![]() NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
Center for Molecular Medicine (Sweden) | Director/Board Member Corporate Officer/Principal | ||
NICOCCINO HOLDING AB | Tobacco | Director/Board Member Director of Finance/CFO | |
SALTX TECHNOLOGY HOLDING AB | Electronic Production Equipment | Chairman Chief Executive Officer | |
DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Blasieholmen Investment Group AB | Director/Board Member Director/Board Member | ||
INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director/Board Member Founder | |
AnaMar AB
![]() AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Astra Arcus AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Vetenskapsrådet | Director/Board Member Corporate Officer/Principal | ||
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Fastilium Property Group AB
![]() Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Chief Executive Officer | |
Din Bostad Sverige AB
![]() Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Real Estate Development | Director/Board Member Chief Tech/Sci/R&D Officer | |
BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Founder | |
Nanyang Technological University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
iNovacia AB
![]() iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
European Society for Medical Oncology
![]() European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President President | |
INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Newron Sweden AB
![]() Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Gesynta Pharma AB
![]() Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder | |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Klaria AB
![]() Klaria AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Estadísticas
Internacional
Suecia | 44 |
Estados Unidos | 3 |
Dinamarca | 3 |
Reino Unido | 2 |
Singapur | 2 |
Sectorial
Health Technology | 29 |
Consumer Services | 6 |
Finance | 6 |
Health Services | 4 |
Commercial Services | 4 |
Operativa
Director/Board Member | 421 |
Corporate Officer/Principal | 225 |
Chairman | 100 |
Independent Dir/Board Member | 75 |
Founder | 69 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Anders Gabrielsen
- Conexiones Empresas